chrX-47223642-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_006201.5(CDK16):c.85G>A(p.Glu29Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000413 in 1,209,659 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000036 ( 0 hom. 1 hem. )
Consequence
CDK16
NM_006201.5 missense
NM_006201.5 missense
Scores
2
9
6
Clinical Significance
Conservation
PhyloP100: 5.34
Genes affected
CDK16 (HGNC:8749): (cyclin dependent kinase 16) The protein encoded by this gene belongs to the cdc2/cdkx subfamily of the ser/thr family of protein kinases. It may play a role in signal transduction cascades in terminally differentiated cells; in exocytosis; and in transport of secretory cargo from the endoplasmic reticulum. This gene is thought to escape X inactivation. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.36498713).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDK16 | NM_006201.5 | c.85G>A | p.Glu29Lys | missense_variant | 2/16 | ENST00000357227.9 | NP_006192.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDK16 | ENST00000357227.9 | c.85G>A | p.Glu29Lys | missense_variant | 2/16 | 1 | NM_006201.5 | ENSP00000349762.4 |
Frequencies
GnomAD3 genomes AF: 0.00000894 AC: 1AN: 111823Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33983
GnomAD3 genomes
AF:
AC:
1
AN:
111823
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33983
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000364 AC: 4AN: 1097836Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 1AN XY: 363196
GnomAD4 exome
AF:
AC:
4
AN:
1097836
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
363196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000894 AC: 1AN: 111823Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33983
GnomAD4 genome
AF:
AC:
1
AN:
111823
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33983
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2022 | The c.307G>A (p.E103K) alteration is located in exon 2 (coding exon 2) of the CDK16 gene. This alteration results from a G to A substitution at nucleotide position 307, causing the glutamic acid (E) at amino acid position 103 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
.;T;T;T;T;.;T;T;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;.;M;.;.;.;.;M;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;D;N;N;N;N;N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
D;D;T;D;D;D;D;T;D
Polyphen
0.86
.;.;P;.;.;.;.;P;.
Vest4
MutPred
0.22
.;Gain of ubiquitination at E29 (P = 0.0018);Gain of ubiquitination at E29 (P = 0.0018);Gain of ubiquitination at E29 (P = 0.0018);Gain of ubiquitination at E29 (P = 0.0018);Gain of ubiquitination at E29 (P = 0.0018);Gain of ubiquitination at E29 (P = 0.0018);Gain of ubiquitination at E29 (P = 0.0018);.;
MVP
MPC
1.1
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at